The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Sequential chemotherapy with gemcitabine plus carboplatin followed by additional docetaxel for older patients with advanced bladder cancer.
Takahiro Yoneyama
No relevant relationships to disclose
Naoki Sugiyama
No relevant relationships to disclose
Yuuichirou Suzuki
No relevant relationships to disclose
Akiko Okamoto
No relevant relationships to disclose
Hayato Yamamoto
No relevant relationships to disclose
Atsushi Imai
No relevant relationships to disclose
Shingo Hatakeyama
No relevant relationships to disclose
Yasuhiro Hashimoto
No relevant relationships to disclose
Takuya Koie
No relevant relationships to disclose
Chikara Ohyama
No relevant relationships to disclose